Pennsylvania professor concerned about Trump administration's plan to cut medical research funding
After growing concerns, a federal judge has put a temporary hold on the Trump administration's plan to reduce medical research funding. But the National Institutes of Health has lost jobs and there's a slow down on administrative actions.
Doctors say millions of people take medications that resulted from years of research. And there are currently hundreds of potential new treatments in the pipeline.
The pending research cuts have many worried, including a Montgomery County professor who depends on the research.
Equations are always running through Michelle Francl-Donnay's mind at a Bryn Mawr College, where she's a chemistry professor.
Francl-Donnay says her ability to move and work depends on a drug she takes for Parkinson's disease. Without it, she says writing a simple equation on a board would be impossible.
The drug L-Dopa is the standard of care for treating the degenerative disease.
"Without it, I would be disabled," Francl-Donnay said. "For me, it's really given me back my life."
The drug is made from a molecule she admires, calling it magic. But it took years of research to develop.
"Research isn't something where you know, oh, I'm gonna design a drug and make the molecule and I know automatically what this will do," she said. "It's sort of like wandering around and exploring new worlds."
Those research worlds are bracing for funding cutbacks as the Trump administration wants to slash what White House spokesperson Kush Desai calls wasteful spending.
"Contrary to the hysteria, redirecting billions of allocated NIH spending away from opaque administrative expenses means there will be more money and resources available for legitimate scientific research, not less," Desai said.
Francl-Donnay disagrees.
"We'll lose a whole generation of ideas and thoughts and drugs and treatments," Francl-Donnay said.
She's angry about the pending research cuts that she thinks will impact millions of families.
"Shingles, Crohn's disease, cancer, Parkinson's, Alzheimer's. The things that change lives are what's happening in these labs," she said. "Without it, we wouldn't have those treatments. And those touch really everybody."
And it's not just treatments at stake, she's worried that life saving cures could be lost too.
Understanding that science and medicine are complicated and advances take time, she's hoping time doesn't run out.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Jim Cramer on Cardinal Health: 'I am a Believer'
Cardinal Health, Inc. (NYSE:CAH) is one of the 11 stocks on Jim Cramer's radar. Calling Cardinal Health, Inc.'s (NYSE:CAH) upcoming Investor Day a possible needle mover, Cramer said: 'Now, Thursday brings some analyst meetings that could move the needle. Cardinal Health, we've had them on a couple of times, tells a terrific story about how it's much more than a drug middleman. And I believe, I am a believer.' A senior physician in a modern healthcare institution administering medication to a patient. Cardinal Health (NYSE:CAH) provides medical products and services used in various care settings. The company delivers pharmaceuticals, equipment, and support tools while managing distribution, logistics, and pharmacy operations through healthcare-focused technology. On May 14, Cramer extensively commented on the company as he said: 'These stocks, namely Cardinal Health, Cencora, and McKesson, are seemingly perpetual residents on the new high list. Over the long haul, they're some of the best performers out there, and they've done great this year, as is pretty much always the case. And yet, doesn't it always feel like the drug distributors are just one bad day away from falling apart… Let's not forget that the drug distributors are making fortunes right now. Cardinal Health turned in an excellent set of numbers two weeks ago with double-digit earnings growth. Management put through a big boost in their full-year earnings forecast. Cardinal stock jumped 3% in response, climbing from $141 to $145, and it kept running for really a week after that, eventually setting at an all-time high of $154 just last Thursday. What a fabulous move… While we acknowledge the potential of CAH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
an hour ago
- Yahoo
Murdoch's Paper Unloads on RFK Jr. Over Axing Vaccine Board
A Rupert Murdoch-owned paper ripped into Robert F. Kennedy Jr. on Tuesday for gutting the nation's top vaccine advisory panel. The Wall Street Journal published a scathing op-ed a day after Kennedy, a longtime vaccine skeptic, announced the firing spree at the Advisory Committee on Immunization Practices (ACIP) in the paper itself. The ACIP reports to the Centers for Disease Control and Prevention (CDC) on vaccine efficacy. The Secretary of Health and Human Services said he was 'retiring' all 17 members of the advisory committee on vaccines in a 'bold step' to help restore 'public trust.' The move raised alarm bells at a time when health experts fear vaccine skepticism is fueling the nation's largest measles outbreak in around 25 years. 'Most of ACIP's members have received substantial funding from pharmaceutical companies, including those marketing vaccines,' Kennedy wrote, hinting at a plot to push vaccines on Americans. Murdoch's editorial board hit back: 'Mr. Kennedy's beef seems to be that the committee's members know something about vaccines and may have been involved in their research and development.' 'How does he define 'substantial'?' the board asked. The board noted that trial doctors get small payments, typically less than their salaries, from vaccine makers to assist with clinical trials. But 'these trials are double-blinded, meaning doctors don't know which volunteers receive the vaccine or placebo so there's no financial incentive to tilt the data in favor of manufacturers,' the board said. Any conflicts of interest among the committee were also 'honestly handled,' the board said. Kennedy said in a separate announcement that 'a clean sweep is necessary to reestablish public confidence in vaccine science.' 'ACIP new members will prioritize public health and evidence-based medicine. The Committee will no longer function as a rubber stamp for industry profit-taking agendas,' he added. Since joining the Trump administration in January, Kennedy, who is leading the Trump administration's 'Make America Healthy Again' initiative has doubled down on conspiracy theories around shots, including that the measles jab contain 'aborted fetus debris.' 'The MMR vaccine contains millions of particles that are derived from fetal tissue, millions of fragments of human DNA from aborted fetuses,' Kennedy told NBC News' Tom Llamas last month. Kennedy was referring to the combined Measles, Mumps and Rubella vaccine. Vaccines do not contain aborted fetuses, fetal cells, fetal DNA, or fetal debris, according to the Children's Hospital of Philadelphia. The rubella component of the vaccine is developed from a fetal cell line known as WI-38 that originally came from the lung tissue of an elective abortion performed more than five decades ago. No new fetal issue has been used since, and cells used today are thousands of times removed from the original source. Health experts are alarmed by Kennedy's suggestions that the measles jab is unsafe, a claim which contradicts decades of research from the Centers for Disease Control and Prevention. The World Health Organization declared measles eliminated from the United States in 2000 due to the success of vaccination efforts. International travel and growing vaccine hesitancy are thought to be behind its resurgence. The American Medical Association has said Kennedy's decision to gut ACIP undermines 'trust and upends a transparent process that has saved countless lives.' Kennedy wrote in his op-ed for the Journal that ACIP's new members 'won't directly work for the vaccine industry.' 'They will exercise independent judgment, refuse to serve as a rubber stamp, and foster a culture of critical inquiry—unafraid to ask hard questions.' ACIP is set to hold its next meeting on June 25 at the CDC's headquarters.
Yahoo
an hour ago
- Yahoo
Experts Say This Type Of Exercise Is The 'Fountain Of Youth'— Especially If You're Over 50
Aging gracefully isn't just about staying active; it's about choosing the right kind of activity to support your health. Resistance training (such as bodyweight, free weight, and resistance band exercises) is one of the best ways to counter the effects of aging, helping you build up muscle to support daily activities and prevent conditions like osteopenia and osteoporosis that can lead to bone fractures. And even if you've never lifted a weight before, it's never too late to start. 'Weight training is the fountain of youth,' says Abby Bales, PT, DPT, CSCS, founder of Reform Physical Therapy. 'Not only does it help increase and maintain bone density to prevent fractures, but the muscle mass that weight training builds also helps to regulate our blood sugar and metabolism.' Weight lifting can even improve balance and coordination, decreasing the frequency, severity, and likelihood of falls. On top of the physical benefits, resistance training has shown promise in staving off neurological conditions like Alzheimer's and dementia, according to a 2023 study published in Frontiers in Neuroscience, making it a multi-benefit tool for aging well. You can think of lifting weights as your body's best tool to promote resilience, energy, and independence through the aging process. Starting with small, manageable steps—such as incorporating resistance bands or light weights (at first) into your routine—can help you gain confidence and momentum while reaping the long-term benefits. Remember: Building a strength training routine doesn't have to be complicated—it just needs to be consistent. 'Start small, build gradually, and stick with it,' says Bales. She recommends starting with two or three sessions per week. Try rotating between upper body, lower body, and core exercises to keep things balanced. Progress takes time, so be patient. 'Results usually show in six to eight weeks,' Bales explains. The key is to keep showing up and enjoy the process—your future self will thank you. Need some inspiration to get started? Weight lifting later in life doesn't come without its fair share of challenges, but the rewards far outweigh the hurdles. Take it from these inspiring women, who spoke with WH previously about their later-in-life strength training journeys: Marilynn Larkin says not to let fear or self-consciousness hold you back. 'Feel your fear, then go through it,' she previously told WH. Following a cancer diagnosis, lifting weights became a way to push through her fears and embrace all that her body was capable of. '[Weight lifting] is all about allowing your body to reach its full potential and accepting it as it is.' Ginny MacColl recommends starting with a small yet challenging goal and celebrating each milestone—no matter how small, focusing on progress, not perfection. 'Little by little, these small steps lead to big changes,' she previously told WH, after becoming the oldest woman to complete an obstacle on American Ninja Warrior and breaking a Guinness World Record as a result. 'Instead of letting negativity and thoughts like 'I can't' creep in, I focus on getting stronger, physically and mentally. It works.' Michelle Alber says don't wait. After just 18 months of training focused on progressive overload (gradually increasing the weight and intensity of her workouts) and working with a coach to ensure her routine was safe and effective, she reversed her osteoporosis. 'There is never a 'perfect' time to start or a 'right' time to do anything,' she previously told WH. 'Was it hard to make major lifestyle changes at 65? Yes! But it's about choosing your 'hard' and taking control of your life.' You Might Also Like Jennifer Garner Swears By This Retinol Eye Cream These New Kicks Will Help You Smash Your Cross-Training Goals
